Develops precision heart-disease therapies for patients with unmet cardiovascular needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Braveheart Bio is a clinical-stage biotechnology company that develops precision small-molecule therapies targeting cardiovascular disease. It focuses on advancing a proprietary inhibitor designed to improve heart muscle function and treat hypertrophic cardiomyopathy with a novel mechanism. The company’s core mission is to pioneer next-generation treatments that address underlying heart conditions rather than only symptoms.
Bravehaeart Bio Funding
Sign up to gain insights into Bravehaeart Bio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A | Nov 05, 2025 | 185M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Bravehaeart Bio Management Team
Investors
Enavate Sciences
Andreessen Horowitz
OrbiMed Advisors
Forbion Capital Partners
Frazier Life Sciences Management
Bravehaeart Bio Valuations & Financials
View real-time NPM data on Bravehaeart Bio stock including daily Bravehaeart Bio stock price estimates, valuation history, and historical share price information. Access Bravehaeart Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Bravehaeart Bio pricing across six independent market signals. Looking for private company due diligence data sources on Bravehaeart Bio? Get in touch to learn more.
Similar Companies
like Bravehaeart Bio
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
OpenEvidence
Healthcare & Life Sciences
Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
FAQ
We have answers
Bravehaeart Bio stock does not trade on public stock exchanges. Bravehaeart Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Bravehaeart Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Bravehaeart Bio Stock does not trade on public stock exchanges. In order to sell Bravehaeart Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Bravehaeart Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Bravehaeart Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Bravehaeart Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Bravehaeart Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Bravehaeart Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Bravehaeart Bio is a private company and has not had an IPO. There is currently no Bravehaeart Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Bravehaeart Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
